Search In this Thesis
   Search In this Thesis  
العنوان
Serum fibroblast growth factor 19 levels in patients with metabolic syndrome /
المؤلف
Ismail, Fathia El-Hamy Abd El-Menam.
هيئة الاعداد
باحث / فتحية الهامى عبدالمنعم إسماعيل
مشرف / محمد شريف عبدالجواد
مشرف / منى أبوبكر الحسينى
مناقش / ايناس محمود طاهر الخميسى
مناقش / خالد ناجى الفيومى
الموضوع
Metabolic Syndrome. Metabolism - Disorders. Metabolism - Treatment.
تاريخ النشر
2020.
عدد الصفحات
online resource (148 pages) :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب الباطني
تاريخ الإجازة
1/1/2020
مكان الإجازة
جامعة المنصورة - كلية الطب - قسم الامراض الباطنة
الفهرس
Only 14 pages are availabe for public view

from 205

from 205

Abstract

19 (FGF15 and FGF19 are the mouse and human orthologs, respectively), FGF21, and FGF23, are endocrine factors involved in hormone-like metabolic effects through activation of FGF receptors. FGF19 is mainly produced by the enterocytes in the distal part of the small intestine Aim of the work. This study was planned to evaluate the level of FGF19 in patients with metabolic syndrome (according to new IDF definition) and to clarify the correlation, if any, with all its parameters. Patient and Method. This study included 100 subjects who were classified into two groups.